Dabrafenib Mesylate and Nexium 24HR (Esomeprazole Delayed-Release Capsules)
Determining the interaction of Dabrafenib Mesylate and Nexium 24HR (Esomeprazole Delayed-Release Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: esomeprazole
Brand name: NexIUM 24HR, Esomeprazole Strontium, Nexium, Nexium, Nexium IV
Synonyms: NexIUM 24HR (Esomeprazole Delayed-Release Tablets)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-NexIUM 24HR (Esomeprazole Delayed-Release Tablets)
- Dabrafenib Mesylate-Nexium Capsules
- Dabrafenib Mesylate-Nexium I.V.
- Dabrafenib Mesylate-Nexium I.V. Injection
- Dabrafenib Mesylate-Nexium Oral
- Dabrafenib Mesylate-Nexplanon
- Nexium 24HR (Esomeprazole Delayed-Release Capsules)-Dacarbazine
- Nexium 24HR (Esomeprazole Delayed-Release Capsules)-Dacarbazine Intravenous, Injection
- Nexium 24HR (Esomeprazole Delayed-Release Capsules)-Daclatasvir
- Nexium 24HR (Esomeprazole Delayed-Release Capsules)-Daclatasvir Dihydrochloride
- Nexium 24HR (Esomeprazole Delayed-Release Capsules)-Daclizumab
- Nexium 24HR (Esomeprazole Delayed-Release Capsules)-Daclizumab Subcutaneous